Integrin expression and survival in human breast cancer

European Journal of Surgical Oncology

Volumn 30, Issue 5, 2004, Pages 484-489

  Berry, M G ^a   Gui, G P H ^b   Wells, C A ^a   Carpenter, R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Cell adhesion; Extracellular matrix; Integrin

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; CELL ADHESION MOLECULE; INTEGRIN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL ASSESSMENT; MEDICAL RESEARCH; METASTASIS POTENTIAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 2542552635     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.01.016     Document Type: Article

References (31)

1. McMurray RW. Adhesion molecules in autoimmune disease. Semin Arthritis Rheum 1996;25:215-233.
2. Hillis GS, MacLeod AM. Integrins and disease. Clin Sci 1996; 91:639-650.
3. Newham P, Humphries MJ. Integrin adhesion receptors: structure, function and implications for biomedicine. Mol Med Today 1996;2:304-313.
4. Gui GPH, Puddefoot JR, Vinson GP, Wells CA, Carpenter R. Modulation of very late activation-2 laminin receptor function in breast cancer metastasis. Surgery 1995;118: 245-250.
5. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990;4:2868-2890.
6. Clarke EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995;268:233-239.
7. Gui GPH, Puddefoot JR, Vinson GP, Wells CA, Carpenter R. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br J Surg 1995;82:1192-1196.
8. Doerr ME, Jones JI. The roles of integrins and extracellular-matrix proteins in the insulin-tike growth-factor 1-stimulated chemotaxis of human breast cancer cells. J Biol Chem 1996;271:2443-2447.
9. Berry MG, Puddefoot JR, Vinson GP, Goode AW, Carpenter R. Integrin-mediated invasion of human breast cancer cells through the extracellular matrix. Eur J Surg Oncol 1998;24: 353.
10. Gui GPH, Wells CA, Yeomans P, Jordan S, Vinson GP, Carpenter R. Integrin expression on fine needle aspiration cytology: a novel predictor of axillary nodal metastasis. Eur J Surg Oncol 1996;22:254-258.
11. Elston CW, Ellis IO, Goulding H, Pinder SE. The breast. In: Elston CW, Ellis IO (eds) Systemic pathology, 3rd ed. London: Churchill Livingstone, 1998.
12. Haybittle JL, Blamey RW, Elston CW et al. A prognostic index in primary breast cancer. Br J Cancer 1982;45:361-366.
13. Walker RA, Jones JL, Chappell S, Walsh T, Shaw JA. Molecular pathology of breast cancer and its application to clinical management. Cancer Metastasis Rev 1997;16:5-27.
14. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL. Tumour angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, oestrogen receptor, and survival. Breast Cancer Res Treat 1994; 29:109-116.
15. 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995; 55:901-906.
16. Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Menard S. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumour cells. Clin Cancer Res 1998;4: 407-410.
17. Gasparini G, Brooks PC, Biganzoli E et al. Vascular integrin alpha 5 beta 3: a new prognostic indicator in breast cancer. Clin Cancer Res 1998;4:2625-2634.
18. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Reduced E-cadherin expression is associated with invasiveness and unfavourable prognosis in breast cancer. Am J Clin Pathol 1996;105:394-402.
19. Guriec N, Marcellini L, Gairard B et al. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis 1996;16:19-26.
20. Hynes RO. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992;69:11-25.
21. Liotta LA. Tumour invasion and metastases-role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 1986;46:1-7.
22. Zutter MM, Mazoujian G, Santoro SA. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 1990;137:863-870.
23. Koukoulis GK, Virtanen I, Korhonen M, Laitinen L, Quaranta V, Gould VE. Immunohistochemical localisation of integrins in the normal, hyperplastic and neoplastic breast. Am J Pathol 1991;139:787-799.
24. 3 subunits of VLA integrins in malignant mammary tumours. J Pathol 1991;165:25-32.
25. 3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 1996;63:169-173.
26. Domingo A, Gonzalez-Barca E, Castellsague X et al. Expression of adhesion molecules in 113 patients with B-cell chronic lymphocytic leukaemia: relationship with clinico-prognostic features. Leuk Res 1997;21:67-73.
27. Begum NA, Mori M, Matsumata T, Takenaka K, Sugimachi K, Barnard GF. Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma. Hepatology 1995;22:1447-1455.
28. Gui GPH, Wells CA, Browne PD et al. Integrin expression in primary breast cancer and its relation to axillary nodal status. Surgery 1995;117:102-108.
29. Gui GPH. Breast cancer integrin expression and its relationship to tumour invasion and metastasis. MS thesis, University of London; 1996.
30. Gui GPH, Wells CA, Yeomans P, Jordan S, Carpenter R. Integrin expression in normal, benign and malignant human breast tissue. Br J Surg 1994;81:748.
31. Sager R, Anisowicz A, Neveu M, Liang P, Sotiropoutou G. Identification by differential display of alpha 6 integrin as a candidate tumour suppressor gene. FASEB J 1993;7: 964-970.